Product Overview

Syncapone 100 mg is a prescription medication that combines three active ingredients—levodopa, carbidopa, and entacapone—designed to manage the symptoms of Parkinson’s disease. Manufactured by Sun Pharmaceutical Industries Ltd, this product is available in strengths of 100 mg per tablet and is supplied in strips containing ten tablets. Pack options include 60, 90, or 120 tablets, providing flexibility for long‑term therapy. The medication is classified under neurology drugs and is intended for oral administration.

What is Syncapone 100 mg (Levodopa/Carbidopa/Entacapone)

Syncapone works by replenishing dopamine, a neurotransmitter that is depleted in Parkinson’s disease. Levodopa is converted to dopamine in the brain, while carbidopa inhibits the peripheral conversion of levodopa to dopamine, enhancing its availability in the central nervous system. Entacapone extends the effect of levodopa by blocking its breakdown, thereby maintaining steady dopamine levels and reducing the frequency of dosing. This triple‑combination approach helps improve motor function, reduce stiffness, and lessen tremor.

Uses and Benefits

The primary indication for Syncapone is the treatment of Parkinson’s disease, particularly when symptoms progress beyond the scope of monotherapy with levodopa or when fluctuations in motor response occur. Clinical studies have demonstrated that the addition of entacapone reduces the “off” periods—times when medication effectiveness wanes—by up to 30 percent, allowing patients to maintain smoother motor control throughout the day. Additional benefits include improved activities of daily living, decreased need for rescue medication, and potential delay in the emergence of dyskinesia associated with long‑term levodopa therapy.

How It Works

Inside the brain, levodopa crosses the blood‑brain barrier and is transformed into dopamine by the enzyme aromatic L‑amino acid decarboxylase. Carbidopa, co‑administered with levodopa, prevents this conversion from occurring outside the brain, ensuring that a higher proportion of levodopa reaches the central nervous system where it is needed. Entacapone, a catechol‑O‑methyltransferase (COMT) inhibitor, slows the metabolism of levodopa in the liver and periphery, prolonging its plasma concentration. Together, these mechanisms create a synergistic effect that stabilizes dopamine levels, reduces motor fluctuations, and enhances overall symptom control.

Dosage Guidelines

Dosage of Syncapone must be individualized based on patient response, disease severity, and tolerability. Typical initiation involves a low dose, often one tablet taken three times daily, with gradual titration upward to achieve optimal symptom management. The tablets are swallowed whole with water and can be taken with or without food, although high‑fat meals may affect absorption. Patients should follow the dosing schedule prescribed by their healthcare provider and should not adjust the dose without medical supervision. It is important to maintain consistent timing each day to sustain steady dopamine concentrations.

Side Effects

Like all medications, Syncapone can cause side effects. Commonly reported adverse reactions include nausea, vomiting, loss of appetite, and constipation. Some patients may experience insomnia, dizziness, or headache. More serious, though less frequent, events can involve cardiovascular complications such as orthostatic hypotension, liver enzyme elevations, or psychiatric symptoms including hallucinations. Patients should report any persistent or severe side effects to their physician promptly. Regular laboratory monitoring may be recommended to assess liver function and electrolyte balance. For detailed scientific background, see the National Institute of Neurological Disorders and Stroke.

Warnings and Precautions

Syncapone is contraindicated in patients with known hypersensitivity to any of its components. Caution is advised in individuals with a history of severe cardiovascular disease, peptic ulcer disease, or psychiatric disorders. The medication may cause sudden drops in blood pressure, especially when standing up quickly; patients should rise slowly from sitting or lying positions. It should not be used in combination with certain medications that inhibit the enzyme CYP2D6 without medical guidance, as this can increase levodopa levels and risk toxicity. Pregnant or breastfeeding women should consult their healthcare provider before use, as the safety profile in these populations is not fully established.

FAQs

What is the main purpose of Syncapone 100 mg?

Syncapone 100 mg is prescribed to treat Parkinson’s disease by providing a combination of levodopa, carbidopa, and entacapone that helps restore dopamine levels in the brain.

Can Syncapone be taken with food?

Yes, the tablets can be taken with or without food, although a high‑fat meal may affect absorption; patients should follow the guidance of their prescribing clinician.

How long does it take to see improvement in symptoms?

Many patients report noticeable motor improvements within one to two weeks of starting therapy, though individual response times can vary based on disease stage and dosage.

Is Syncapone safe for elderly patients?

Clinical experience shows that elderly patients can use Syncapone safely when dosing is carefully titrated and monitored, but they may be more susceptible to side effects such as orthostatic hypotension.

Where can I find the full prescribing information?

Detailed prescribing information and the FDA‑approved label are available through the U.S. Food and Drug Administration website or by contacting your healthcare provider.

Related Products

• Vortidif 20 Mg (Vortioxetine)
• Vortidif 5 Mg (Vortioxetine)
• Pramipex 0.25 mg (Pramipexole)
• Relgin 0.5 mg (Rasagiline)
• Mirtaz 30 Mg (Mirtazapine)
• Lurasidone 40 mg (Generic)
• Ropinirole 1 mg (Generic)
• Adesam 200 mg (Ademetionine/S-Adenosyl Methionine)
• Suminat 25 mg (Sumatriptan)
• Cyclomune Eye Drop (Cyclosporin)
• Glypride 4 mg (Glimepiride)
• Natrise 15 mg (Tolvaptan)